<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873546</url>
  </required_header>
  <id_info>
    <org_study_id>API/2011/24</org_study_id>
    <nct_id>NCT02873546</nct_id>
  </id_info>
  <brief_title>tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia</brief_title>
  <acronym>ALSTICO</acronym>
  <official_title>Evaluation de l'Effet de la tDCS Sur Les Fonctions Cognitives de Patients Souffrant de Maladie d'Alzheimer et Maladies apparentées au Stade léger</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of 10 sessions of anodal transcranial
      Direct Current Stimulation (tDCS - 1 mA) applied to left Cortex DorsoLateral PreFrontal
      (CDLPF) of Alzheimer's or Primary Progressive Aphasia (PPA) patients compared to the
      application of a placebo tDCS (sham procedure) on cognitive functions, which are evaluated at
      short term (1 week post-treatment) and mild term (3 weeks post-treatment).

      After unblinding, patients who received placebo treatment could be received active tDCS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2013</start_date>
  <completion_date type="Anticipated">July 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline cognitive functions at 3 weeks</measure>
    <time_frame>baseline, day 5 and 3 weeks post-tDCS</time_frame>
    <description>neuropsychological assessments include Rapid battery tests (Bereay et al., 2015)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Progressive Primary Aphasia</condition>
  <condition>Early or Mild State</condition>
  <arm_group>
    <arm_group_label>anodal tDCS on left DLPFC (F3)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tDCS is a non-invasive neuromodulation method, which delivers a constant current of low intensity (1 mA) during 30 minutes for 10 sessions. Anode is placed on the scalp facing on left DLPFC (F3) and cathode between Fp2-F8 EEG-repair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS on left DLPFC (F3)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham tDCS differs from active tDCS by the interruption of stimulation after 15 sec and reactivation of the stimulation 15 sec before the end of the session (30 minutes - 10 sessions. Anode is placed on the scalp facing on left DLPFC (F3) and cathode between Fp2-F8 EEG-repair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <description>After locating the stimulation areas, treatment will be delivered during 30-minute session. Treatment will be occur 2 session per day during 5 consecutive days. Subjects will be monitored during tDCS sessions for any side effects or adverse events.</description>
    <arm_group_label>anodal tDCS on left DLPFC (F3)</arm_group_label>
    <arm_group_label>sham tDCS on left DLPFC (F3)</arm_group_label>
    <other_name>EldithDC-NeuroConn Stimulator (NeuroConn Gmbh, Germany)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  National Institute of Neurological and Communicative Disorders and Stroke and the
             Alzheimer's Disease and Related Disorders Association (NINCDS-ADRADA) criteria
             (Alzheimer's patient) OR Gordo-Tempini criteria (PPA's patient)

          -  CDR score ≤ 2

          -  treatment by IAChE ≥ 3 months

          -  MADRS score &lt; 18

          -  w/o severe progressive somatic pathology (especially tumor diseases)

        Exclusion Criteria:

          -  last neuropsychological assessment &lt; 6 months

          -  presence of a specific contraindication for tDCS (e.g. personal history of epilepsy,
             metallic head implant, cardiac pacemaker)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Paquet, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assitance Publique - Hôpitaux Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Bonnin, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universaitaire Dijon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Vandel, MD PhD</last_name>
    <phone>+33381219007</phone>
    <email>pierre.vandel@univ-fcomte.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magali Nicolier, PhD</last_name>
    <phone>+33381219007</phone>
    <email>mnicolier@chu-besancon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Besancon - Clinical Psychiatric Department</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali Nicolier, PhD</last_name>
      <phone>+33381219007</phone>
      <email>mnicolier@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Vandel, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eloi Magnin, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Universitaire Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernard Bonnin, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Bernard Bonnin, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Trojak Benoît, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assistance Publique - Hôpitaux Paris</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène Francisque</last_name>
      <phone>+33140054390</phone>
      <email>helene.francisque@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hélène Francisque</last_name>
    </contact_backup>
    <investigator>
      <last_name>Claire Paquet, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Bereau M, Sylvestre G, Mauny F, Puyraveau M, Baudier F, Magnin E, Berger E, Vandel P, Galmiche J, Chopard G. [Assessment of 10 years of memory consultations in the Franche-Comté: Description and analysis of the RAPID regional database]. Rev Neurol (Paris). 2015 Sep;171(8-9):655-61. doi: 10.1016/j.neurol.2015.04.008. Epub 2015 Jul 23. French.</citation>
    <PMID>26212200</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <last_update_submitted>October 12, 2017</last_update_submitted>
  <last_update_submitted_qc>October 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Aphasia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

